Cholamandalam Finance Q2 Results Review - Inline; Weak Asset Quality In New Portfolio Concerning: Systematix

AUM growth was aided by healthy growth across product segments viz vehicle finance, LAP, home loan, new business segments.

A person holding Indian two rupees banknotes for photograph. (Photo: Usha Kunji/ Source: BQ Prime).

BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

Systematix Research Report

Cholamandalam Investment and Finance Company Ltd. reported in-line operational performance, aided by 10 basis points expansion in net interest margins to 7.4% and 42% YoY growth in assets under management.

AUM growth was aided by healthy growth across product segments viz vehicle finance, loan against property, home loan, new business segments. Opex/ AUM ratio increased to 3.2% (versus 2.8% in Q1) due to increments paid during the quarter.

In terms of asset quality, while overall stage-III assets improved marginally to 2.96% from 3.06% in Q1, stage-III assets in new business verticals increased sharply from 1.01% in Q1 to 1.42%, largely led by Consumer and Small Enterprises Loans partnership portfolio (4.7% gross stage-III) .

Stage III provision cover stood at 47.3% versus 45.4% in Q1. While we remain positive on Cholamandalam's growth front, we would be watchful on asset quality in the new business portfolio, as the portfolio is yet to complete one full cycle.

We believe the stock is fairly valued at 4.0 times FY25 book value with return on asset/return on equity of 2.5%/ 18.0%. Hence, we maintain 'Hold' rating with a price target of Rs 1,100 (unchanged), valuing it at 3.75 times 25 book value.

Click on the attachment to read the full report:

Systematix Cholamandalam Finance Q2FY24 Results Review.pdf
Read Document

Also Read: Mahindra Finance Q2 Results Review - Another Quarter Of Disappointment; Growth Guidance Lowered: Systematix

DISCLAIMER

This report is authored by an external party. BQ Prime does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BQ Prime.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

lock-gif
To continue reading this story You must be an existing Premium User
Watch LIVE TV, Get Stock Market Updates, Top Business, IPO and Latest News on NDTV Profit.
GET REGULAR UPDATES